# Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

> **NCT07224737** · — · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 230 (actual)

## Conditions studied

- Intrahepatic Cholangiocarcinoma (Icc)

## Interventions

- **DIAGNOSTIC_TEST:** EXOMIC small RNA sequencing
- **DIAGNOSTIC_TEST:** EXOMIC assay (qRT-PCR validation)

## Key facts

- **NCT ID:** NCT07224737
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-21
- **Primary completion:** 2026-01-18
- **Final completion:** 2026-02-18
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224737, "Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07224737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*